Position in INDV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$47,620,156
-$19,200,049 QoQ
Shares Held
1,160,618
-47.1% QoQ
Ownership
0.983%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 337 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in INDV Over Time
Shares Held
Position Value (USD)
Derivatives in INDV
reported options exposure · as of Jun 30, 2026CallValue
$820,600
CallShares
20,000
PutValue
$20,515,000
PutShares
500,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. INDV ranks #11 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,643,241 | $261,803,294 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
9,910,822 | $243,905,327 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
220,616 | $119,536,366 | |
| 4 | VTRS |
Viatris Inc
|
6,092,296 | $96,745,659 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
835,494 | $92,689,703 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
2,660,810 | $92,250,281 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
545,937 | $92,012,220 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,140,065 | $72,505,400 |
All Filings in INDV
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,515,000 | 500,000 | Put | Defined | 2026-08-13 | |
| 2026-06-30 | $820,600 | 20,000 | Call | Defined | 2026-08-13 | |
| 2026-06-30 | $47,620,156 | 1,160,618 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $66,820,205 | 2,192,264 | Shares | Defined | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||